View in EDS

A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer.

Saved in:
Bibliographic Details
Title: A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer.
Authors: Lind JS; Departments of Pulmonary Diseases, VU University Medical Center Amsterdam, Amsterdam, the Netherlands., Dingemans AM, Groen HJ, Thunnissen FB, Bekers O, Heideman DA, Honeywell RJ, Giovannetti E, Peters GJ, Postmus PE, van Suylen RJ, Smit EF
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2010 Jun 01; Vol. 16 (11), pp. 3078-87. Date of Electronic Publication: 2010 Apr 15.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 20395213
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lind+JS%22">Lind JS</searchLink>; Departments of Pulmonary Diseases, VU University Medical Center Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Dingemans+AM%22">Dingemans AM</searchLink><br /><searchLink fieldCode="AU" term="%22Groen+HJ%22">Groen HJ</searchLink><br /><searchLink fieldCode="AU" term="%22Thunnissen+FB%22">Thunnissen FB</searchLink><br /><searchLink fieldCode="AU" term="%22Bekers+O%22">Bekers O</searchLink><br /><searchLink fieldCode="AU" term="%22Heideman+DA%22">Heideman DA</searchLink><br /><searchLink fieldCode="AU" term="%22Honeywell+RJ%22">Honeywell RJ</searchLink><br /><searchLink fieldCode="AU" term="%22Giovannetti+E%22">Giovannetti E</searchLink><br /><searchLink fieldCode="AU" term="%22Peters+GJ%22">Peters GJ</searchLink><br /><searchLink fieldCode="AU" term="%22Postmus+PE%22">Postmus PE</searchLink><br /><searchLink fieldCode="AU" term="%22van+Suylen+RJ%22">van Suylen RJ</searchLink><br /><searchLink fieldCode="AU" term="%22Smit+EF%22">Smit EF</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2010 Jun 01; Vol. 16 (11), pp. 3078-87. <i>Date of Electronic Publication: </i>2010 Apr 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20395213
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1078-0432.CCR-09-3033
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3078
    Titles:
      – TitleFull: A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lind JS
      – PersonEntity:
          Name:
            NameFull: Dingemans AM
      – PersonEntity:
          Name:
            NameFull: Groen HJ
      – PersonEntity:
          Name:
            NameFull: Thunnissen FB
      – PersonEntity:
          Name:
            NameFull: Bekers O
      – PersonEntity:
          Name:
            NameFull: Heideman DA
      – PersonEntity:
          Name:
            NameFull: Honeywell RJ
      – PersonEntity:
          Name:
            NameFull: Giovannetti E
      – PersonEntity:
          Name:
            NameFull: Peters GJ
      – PersonEntity:
          Name:
            NameFull: Postmus PE
      – PersonEntity:
          Name:
            NameFull: van Suylen RJ
      – PersonEntity:
          Name:
            NameFull: Smit EF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2010 Jun 01
              Type: published
              Y: 2010
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3265
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research
              Type: main
ResultId 1